---
title: "Hubei Huaqiang High-Tech Co., Ltd. (688151.SH)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/688151.SH.md"
symbol: "688151.SH"
name: "Hubei Huaqiang High-Tech Co., Ltd."
industry: "Health Care Supplies"
datetime: "2026-05-21T16:13:09.391Z"
locales:
  - [en](https://longbridge.com/en/quote/688151.SH.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/688151.SH.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/688151.SH.md)
---

# Hubei Huaqiang High-Tech Co., Ltd. (688151.SH)

## Company Overview

Hubei Huaqiang High-Tech Co., Ltd. research, develops, produces, and sells special protective equipment, pharmaceutical packaging, and medical devices in China. The company operates as a chemical defense military enterprise in special protection. It offers personal protective equipment, such as anti-virus clothing and boot covers, and gas masks; collective protective equipment, comprising cooperative supporting and demobilized troops products, pre-filters, air inlet components, particle filters, filter absorbers, poison filter ventilation devices, and collective protection system equipment; and chemical defense equipment for national civil air defense projects, such as civil air defense filters and doors, and impregnated carbon.

| Item | Detail |
|------|--------|
| Industry | Health Care Supplies |
| Exchange | CN Market |
| Website | [www.hqtc.com;http://hqtc.csgc.com.cn](https://www.hqtc.com;http://hqtc.csgc.com.cn) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: C
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-21T04:30:13.000Z

**Overall: C (0.45)**

**Industry**: Health Care Supplies

| Metric | Value |
|--------|-------|
| Industry Ranking | 22 / 40 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Blend - Stocks in which the company has both growth and mature businesses.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: C

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 20.18% |  |
| Net Profit YoY | 360.83% |  |
| P/B Ratio | 1.58 |  |
| Dividend Ratio | 0.22% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 6691082290.59 |  |
| Revenue | 665707824.59 |  |

#### Multi Score Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 1.12% | D |
| Profit Margin | 7.09% | B |
| Gross Margin | 21.31% | D |
| Revenue YoY | 20.18% | B |
| Net Profit YoY | 360.83% | A |
| Total Assets YoY | -1.64% | D |
| Net Assets YoY | 0.77% | C |
| Cash Flow Margin | -20.69% | D |
| OCF YoY | 20.18% | B |
| Turnover | 0.14 | E |
| Gearing Ratio | 11.24% | A |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Hubei Huaqiang High-Tech Co., Ltd.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "20.18%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "360.83%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "1.58",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.22%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "6691082290.59",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "665707824.59",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "1.12%",
          "rating": "D"
        },
        {
          "name": "Profit Margin",
          "value": "7.09%",
          "rating": "B"
        },
        {
          "name": "Gross Margin",
          "value": "21.31%",
          "rating": "D"
        },
        {
          "name": "Revenue YoY",
          "value": "20.18%",
          "rating": "B"
        },
        {
          "name": "Net Profit YoY",
          "value": "360.83%",
          "rating": "A"
        },
        {
          "name": "Total Assets YoY",
          "value": "-1.64%",
          "rating": "D"
        },
        {
          "name": "Net Assets YoY",
          "value": "0.77%",
          "rating": "C"
        },
        {
          "name": "Cash Flow Margin",
          "value": "-20.69%",
          "rating": "D"
        },
        {
          "name": "OCF YoY",
          "value": "20.18%",
          "rating": "B"
        },
        {
          "name": "Turnover",
          "value": "0.14",
          "rating": "E"
        },
        {
          "name": "Gearing Ratio",
          "value": "11.24%",
          "rating": "A"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 137.50 | 27/40 | 472086.64 | 848.79 | 576.93 |
| PB | 1.54 | 10/40 | 1.89 | 1.73 | 1.65 |
| PS (TTM) | 9.75 | 32/40 | 14.74 | 13.42 | 12.62 |
| Dividend Yield | 0.23% | 34/40 | 0.27% | 0.22% | 0.21% |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Snibe (300832.SZ) | A | D | C | A | C | B |
| 02 | Winner Medical (300888.SZ) | B | B | B | B | B | B |
| 03 | Fuerjia (301371.SZ) | B | C | D | A | B | B |
| 04 | MTM (688029.SH) | B | B | B | A | B | B |
| 05 | Endovastec (688016.SH) | A | B | D | A | B | B |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/688151.SH/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/688151.SH/norm.md)
- [Related News](https://longbridge.com/en/quote/688151.SH/news.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**